Page last updated: 2024-10-31

moclobemide and Acathisia, Drug-Induced

moclobemide has been researched along with Acathisia, Drug-Induced in 3 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
"Tardive akathisia (TA) is a well-documented side-effect of neuroleptic treatment."1.28Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study. ( Demling, J; Ebert, D, 1991)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gillman, PK1
Fischer, P1
Ebert, D1
Demling, J1

Other Studies

3 other studies available for moclobemide and Acathisia, Drug-Induced

ArticleYear
Possible serotonin syndrome with moclobemide and pethidine.
    The Medical journal of Australia, 1995, May-15, Volume: 162, Issue:10

    Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Benzamides; Female; Humans; Meperidine; Moclob

1995
Serotonin syndrome in the elderly after antidepressive monotherapy.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6

    Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Benzamid

1995
Successful treatment of tardive akathisia with moclobemide, a reversible and selective monoamine-oxidase-A inhibitor. A case study.
    Pharmacopsychiatry, 1991, Volume: 24, Issue:6

    Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Benzamides; Depressive Disorder; Humans; Male; Middle

1991